|
|
| | 2-Chloro-5-fluoronicotinic acid Basic information | | Application |
| | 2-Chloro-5-fluoronicotinic acid Chemical Properties |
| Melting point | 141-142°C | | Boiling point | 297.0±35.0 °C(Predicted) | | density | 1.576±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | pka | 1.67±0.25(Predicted) | | form | powder | | color | Off-white | | InChI | InChI=1S/C6H3ClFNO2/c7-5-4(6(10)11)1-3(8)2-9-5/h1-2H,(H,10,11) | | InChIKey | WMADTZFXZAITIR-UHFFFAOYSA-N | | SMILES | C1(Cl)=NC=C(F)C=C1C(O)=O | | CAS DataBase Reference | 38186-88-8(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 7/9-24/25-26-36/37-38-51 | | WGK Germany | 3 | | HazardClass | IRRITANT | | HS Code | 2933399990 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
| | 2-Chloro-5-fluoronicotinic acid Usage And Synthesis |
| Application | 2-Chloro-5-fluoronicotinic acid possesses unique chemical properties and pharmaceutical activity, making it an intermediate in many pharmaceuticals and pesticides with a very broad application prospect. It can also be used as a pharmaceutical and pharmaceutical intermediate, a hair dyeing auxiliary agent, a polymer stabilizer, an antioxidant in photosensitive materials, and an anti-fogging agent, among other applications. 2-Chloro-5-fluoronicotinic acid is also an intermediate in many high-value-added drugs, including diabetes medications, antidepressants, antitumor drugs, local anesthetics, and antihypertensive drugs, and it has applications in the fields of antihypertensive, antitumor, and anticoccosis treatments. | | Synthesis Reference(s) | The Journal of Organic Chemistry, 71, p. 4021, 2006 DOI: 10.1021/jo0602571 | | Synthesis | The general procedure for the synthesis of 2-chloro-5-fluoronicotinic acid from 2,6-dichloro-5-fluoropyridine-3-carboxylic acid is as follows:
1. Synthesis of the intermediate 5-fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine:
- Reagents and conditions:
i. Pd(OAc)2, PPh3, Et3N, HCOOH.
ii. 1) (COCl)2, CH2Cl2, catalytic amount of DMF; 2) NH3(g), Dioxane; iii.
iii. TFAA, Et3N, CH2Cl2, 0 °C.
H2NNH2-H2O, n-butanol, reflux. iv.
2. Synthesis of 2-chloro-5-fluoronicotinic acid (6):
- Degassed DMF (270 μL), Pd(OAc)2 (0.05 eq, 2.7 g, 11.9 mmol), PPh3 (0.1 eq, 6.2 g, 23.8 mmol), and degassed Et3N (6 eq, 200 mL, 1428.6 mmol) were added to a round-bottomed flask under N2 atmosphere.
- The mixture was stirred for 20 min and then HCOOH (3 eq, 28 mL, 714.3 mmol) was added.
- After 5 min, 2,6-dichloro-5-fluoronicotinic acid (50 g, 238.1 mmol) was added.
- The mixture was stirred at 50 °C and the progress of the reaction was monitored by 1H NMR analysis.
- When all ingredients were consumed (~24 h), the mixture was cooled to 0 °C and water (500 mL) was added.
- After 20 minutes, the mixture was filtered through a diatomaceous earth pad and rinsed with water.
- The mixture was alkalized to pH 9 with 30% NaOH aqueous solution and then washed with EtOAc (2x).
- 12N HCl was added slowly to pH 1 and treated with a saturated solution of NaCl.
- The mixture was extracted with EtOAc (3x), the organic phases were combined, washed with brine, dried (Na2SO4), and concentrated under reduced pressure to give 37 g (88% yield) of a beige solid, which could be used in the next step without further purification.
- 1H NMR (DMSO-d6, 300MHz): δ 8.16 (dd, 1H); 8.58 (d, 1H). | | References | [1] Patent: WO2008/77086, 2008, A1. Location in patent: Page/Page column 56-57 [2] Patent: WO2009/18415, 2009, A1. Location in patent: Page/Page column title page; 35 [3] Patent: WO2008/112642, 2008, A1. Location in patent: Page/Page column 50; 50-51 [4] Patent: WO2008/112646, 2008, A1. Location in patent: Page/Page column 49-50 [5] Patent: WO2009/145814, 2009, A2. Location in patent: Page/Page column 49 |
| | 2-Chloro-5-fluoronicotinic acid Preparation Products And Raw materials |
|